Related references
Note: Only part of the references are listed.Passive transfer of neutralizing mAb KD-247 reduces plasma viral load in patients chronically infected with HIV-1
Shuzo Matsushita et al.
AIDS (2015)
Broadly Neutralizing Anti-HIV-1 Antibodies Require Fc Effector Functions for In Vivo Activity
Stylianos Bournazos et al.
CELL (2014)
Broadly Neutralizing Antibodies and Viral Inducers Decrease Rebound from HIV-1 Latent Reservoirs in Humanized Mice
Ariel Halper-Stromberg et al.
CELL (2014)
Structural Insights on the Role of Antibodies in HIV-1 Vaccine and Therapy
Anthony P. West et al.
CELL (2014)
Broadly Neutralizing HIV Antibodies Define a Glycan-Dependent Epitope on the Prefusion Conformation of gp41 on Cleaved Envelope Trimers
Emilia Falkowska et al.
IMMUNITY (2014)
Enhanced HIV-1 immunotherapy by commonly arising antibodies that target virus escape variants
Florian Klein et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies
Nicole A. Doria-Rose et al.
NATURE (2014)
The Immunologic Effects of Mesalamine in Treated HIV-Infected Individuals with Incomplete CD4+T Cell Recovery: A Randomized Crossover Trial
Ma Somsouk et al.
PLOS ONE (2014)
Antibody 8ANC195 Reveals a Site of Broad Vulnerability on the HIV-1 Envelope Spike
Louise Scharf et al.
CELL REPORTS (2014)
Somatic Mutations of the Immunoglobulin Framework Are Generally Required for Broad and Potent HIV-1 Neutralization
Florian Klein et al.
CELL (2013)
Multidonor Analysis Reveals Structural Elements, Genetic Determinants, and Maturation Pathway for HIV-1 Neutralization by VRC01-Class Antibodies
Tongqing Zhou et al.
IMMUNITY (2013)
The end of AIDS: HIV infection as a chronic disease
Steven G. Deeks et al.
LANCET (2013)
Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus
Hua-Xin Liao et al.
NATURE (2013)
HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice
Joshua A. Horwitz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Computational analysis of anti-HIV-1 antibody neutralization panel data to identify potential functional epitope residues
Anthony P. West et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Antibodies in HIV-1 Vaccine Development and Therapy
Florian Klein et al.
SCIENCE (2013)
Rapid Quantification of the Latent Reservoir for HIV-1 Using a Viral Outgrowth Assay
Gregory M. Laird et al.
PLOS PATHOGENS (2013)
Pharmacodynamics, Safety, and Pharmacokinetics of BMS-663068, an Oral HIV-1 Attachment Inhibitor in HIV-1-Infected Subjects
Richard E. Nettles et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Antibody-based protection against HIV infection by vectored immunoprophylaxis
Alejandro B. Balazs et al.
NATURE (2012)
HIV therapy by a combination of broadly neutralizing antibodies in humanized mice
Florian Klein et al.
NATURE (2012)
Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo
Brian Moldt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Increasing the Potency and Breadth of an HIV Antibody by Using Structure-Based Rational Design
Ron Diskin et al.
SCIENCE (2011)
Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding
Johannes F. Scheid et al.
SCIENCE (2011)
Antibody-mediated modulation of immune responses
Falk Nimmerjahn et al.
IMMUNOLOGICAL REVIEWS (2010)
Cross-Reactive Neutralizing Humoral Immunity Does Not Protect from HIV Type 1 Disease Progression
Zelda Euler et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation
Florencia Pereyra et al.
SCIENCE (2010)
New Algorithms and Methods to Estimate Maximum-Likelihood Phylogenies: Assessing the Performance of PhyML 3.0
Stephane Guindon et al.
SYSTEMATIC BIOLOGY (2010)
Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals
Johannes F. Scheid et al.
NATURE (2009)
Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing
Jesus F. Salazar-Gonzalez et al.
JOURNAL OF VIROLOGY (2008)
Isolation and propagation of HIV-1 on peripheral blood mononuclear cells
Angelique B. van 't Wout et al.
NATURE PROTOCOLS (2008)
Adjunctive passive immunotherapy in human immunodeficiency virus type 1-infected individuals treated with antiviral therapy during acute and early infection
Saurabh Mehandru et al.
JOURNAL OF VIROLOGY (2007)
Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies
M Li et al.
JOURNAL OF VIROLOGY (2005)
Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies
A Trkola et al.
NATURE MEDICINE (2005)
Passive immunization with the anti-HIV-1 human monoclonal antibody (hMAb) 4E10 and the hMAb combination 4E10/2F5/2G12
C Armbruster et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
WebLogo: A sequence logo generator
GE Crooks et al.
GENOME RESEARCH (2004)
Antibody neutralization and escape by HIV-1
XP Wei et al.
NATURE (2003)
Share Paper
